LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA – Abiomed, Inc. Transaction History
LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA portfolio value:
$3.85M
portfolio value
LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA quarter portfolio value change:
-0.75%
quarter
Abiomed, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | -29K | $245.66 | 15.69K | |
| Q2 2022 | share | Decrease | -0.05% | -8 shares | -1.31M | $247.51 | 15.69K |
| Q1 2022 | share | Decrease | -4.79% | -790 shares | -722K | $331.24 | 15.7K |
| Q4 2021 | share | 0.00% | 0 shares | 555K | $362.06 | 16.49K | |
| Q3 2021 | share | 0.00% | 0 shares | 221K | $325.52 | 16.49K | |
| Q2 2021 | share | 0.00% | 0 shares | -109K | $312.11 | 16.49K | |
| Q1 2021 | share | Decrease | -0.51% | -85 shares | -118K | $318.73 | 16.49K |
| Q4 2020 | share | 0.00% | 0 shares | 781K | $324.2 | 16.57K | |
| Q3 2020 | share | Decrease | -2.27% | -385 shares | 497K | $277.06 | 16.57K |
| Q2 2020 | share | Increase | +2.98% | 490 shares | 1.70M | $241.56 | 16.96K |
| Q1 2020 | share | Increase | +3.42% | 545 shares | -327K | $145.16 | 16.47K |
| Q4 2019 | share | Increase | +11.32% | 1.62K shares | 173K | $170.59 | 15.92K |
| Q3 2019 | share | Increase | +48.86% | 4.69K shares | 41K | $177.89 | 14.30K |
| Q2 2019 | share | Increase | +120025.00% | 9.60K shares | 2.50M | $260.49 | 9.61K |
| Q1 2019 | share | 0.00% | 0 shares | -1K | $285.59 | 8 | |
| Q4 2018 | share | 0.00% | 0 shares | -1K | $325.04 | 8 | |
| Q3 2018 | share | 0.00% | 0 shares | 1K | $449.75 | 8 | |
| Q2 2018 | share | 0.00% | 0 shares | 1K | $409.05 | 8 | |
| Q1 2018 | share | 0.00% | 0 shares | 1K | $290.99 | 8 | |
| Q4 2017 | share | 0.00% | 0 shares | 0 | $187.41 | 8 | |
| Q3 2017 | share | Increase | 0.00% | 8 shares | 1K | $168.6 | 8 |